Pfizer led various process optimization and redesign initiatives to improve efficiency and customer satisfaction. This included redesigning the country and site selection process, which increased customer satisfaction by over 200% while decreasing cycle times. Pfizer also implemented a clinical trial contracting and budgeting process to focus on customer satisfaction, agile workflows, and waste reduction. Continuous improvement efforts in business technology and finance operations achieved $21 million in cost savings in 2009. Pfizer created deployment strategies for a global travel and expense system and established a European financial shared services contact center supporting multiple languages across 19 European markets.
It is defined by Robert Kaplan and David Norton as a powerful strategic measurement system, communication tools and innovative feedback & learning tool that “… translates strategy into measures that uniquely communicate your vision to the organization”
It is defined by Robert Kaplan and David Norton as a powerful strategic measurement system, communication tools and innovative feedback & learning tool that “… translates strategy into measures that uniquely communicate your vision to the organization”
SlideShare now has a player specifically designed for infographics. Upload your infographics now and see them take off! Need advice on creating infographics? This presentation includes tips for producing stand-out infographics. Read more about the new SlideShare infographics player here: http://wp.me/p24NNG-2ay
This infographic was designed by Column Five: http://columnfivemedia.com/
SlideShare now has a player specifically designed for infographics. Upload your infographics now and see them take off! Need advice on creating infographics? This presentation includes tips for producing stand-out infographics. Read more about the new SlideShare infographics player here: http://wp.me/p24NNG-2ay
This infographic was designed by Column Five: http://columnfivemedia.com/
Are you new to SlideShare? Are you looking to fine tune your channel plan? Are you using SlideShare but are looking for ways to enhance what you're doing? How can you use SlideShare for content marketing tactics such as lead generation, calls-to-action to other pieces of your content, or thought leadership? Read more from the CMI team in their latest SlideShare presentation on SlideShare.
No need to wonder how the best on SlideShare do it. The Masters of SlideShare provides storytelling, design, customization and promotion tips from 13 experts of the form. Learn what it takes to master this type of content marketing yourself.
10 Ways to Win at SlideShare SEO & Presentation OptimizationOneupweb
Thank you, SlideShare, for teaching us that PowerPoint presentations don't have to be a total bore. But in order to tap SlideShare's 60 million global users, you must optimize. Here are 10 quick tips to make your next presentation highly engaging, shareable and well worth the effort.
For more content marketing tips: http://www.oneupweb.com/blog/
Each month, join us as we highlight and discuss hot topics ranging from the future of higher education to wearable technology, best productivity hacks and secrets to hiring top talent. Upload your SlideShares, and share your expertise with the world!
Not sure what to share on SlideShare?
SlideShares that inform, inspire and educate attract the most views. Beyond that, ideas for what you can upload are limitless. We’ve selected a few popular examples to get your creative juices flowing.
How to Make Awesome SlideShares: Tips & TricksSlideShare
Turbocharge your online presence with SlideShare. We provide the best tips and tricks for succeeding on SlideShare. Get ideas for what to upload, tips for designing your deck and more.
Key Points covered
1. Role of Productivity SA in SA especially within Dti
2. How does it help business owners? Cover different services and solutions with contributions
3. How do they screen the entrepreneurs
4. How to get hold of Productivity SA to get help.
Here is the link of the video ...https://youtu.be/qQxzXyZ1wDg
Finding and Mining Value Hidden in Operations - The ProAction GroupThe Proaction Group
In this set of slides, you'll find an overview of ProAction's role, values, a few case studies covering diligence through exit, as well as several team member bios.
How many patients does case series should have In comparison to case reports.pdfpubrica101
Pubrica’s team of researchers and writers create scientific and medical research articles, which may be important resources for authors and practitioners. Pubrica medical writers assist you in creating and revising the introduction by alerting the reader to gaps in the chosen study subject. Our professionals understand the order in which the hypothesis topic is followed by the broad subject, the issue, and the backdrop.
https://pubrica.com/academy/case-study-or-series/how-many-patients-does-case-series-should-have-in-comparison-to-case-reports/
Navigating Challenges: Mental Health, Legislation, and the Prison System in B...Guillermo Rivera
This conference will delve into the intricate intersections between mental health, legal frameworks, and the prison system in Bolivia. It aims to provide a comprehensive overview of the current challenges faced by mental health professionals working within the legislative and correctional landscapes. Topics of discussion will include the prevalence and impact of mental health issues among the incarcerated population, the effectiveness of existing mental health policies and legislation, and potential reforms to enhance the mental health support system within prisons.
CRISPR-Cas9, a revolutionary gene-editing tool, holds immense potential to reshape medicine, agriculture, and our understanding of life. But like any powerful tool, it comes with ethical considerations.
Unveiling CRISPR: This naturally occurring bacterial defense system (crRNA & Cas9 protein) fights viruses. Scientists repurposed it for precise gene editing (correction, deletion, insertion) by targeting specific DNA sequences.
The Promise: CRISPR offers exciting possibilities:
Gene Therapy: Correcting genetic diseases like cystic fibrosis.
Agriculture: Engineering crops resistant to pests and harsh environments.
Research: Studying gene function to unlock new knowledge.
The Peril: Ethical concerns demand attention:
Off-target Effects: Unintended DNA edits can have unforeseen consequences.
Eugenics: Misusing CRISPR for designer babies raises social and ethical questions.
Equity: High costs could limit access to this potentially life-saving technology.
The Path Forward: Responsible development is crucial:
International Collaboration: Clear guidelines are needed for research and human trials.
Public Education: Open discussions ensure informed decisions about CRISPR.
Prioritize Safety and Ethics: Safety and ethical principles must be paramount.
CRISPR offers a powerful tool for a better future, but responsible development and addressing ethical concerns are essential. By prioritizing safety, fostering open dialogue, and ensuring equitable access, we can harness CRISPR's power for the benefit of all. (2998 characters)
Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...ILC- UK
The Healthy Ageing and Prevention Index is an online tool created by ILC that ranks countries on six metrics including, life span, health span, work span, income, environmental performance, and happiness. The Index helps us understand how well countries have adapted to longevity and inform decision makers on what must be done to maximise the economic benefits that comes with living well for longer.
Alongside the 77th World Health Assembly in Geneva on 28 May 2024, we launched the second version of our Index, allowing us to track progress and give new insights into what needs to be done to keep populations healthier for longer.
The speakers included:
Professor Orazio Schillaci, Minister of Health, Italy
Dr Hans Groth, Chairman of the Board, World Demographic & Ageing Forum
Professor Ilona Kickbusch, Founder and Chair, Global Health Centre, Geneva Graduate Institute and co-chair, World Health Summit Council
Dr Natasha Azzopardi Muscat, Director, Country Health Policies and Systems Division, World Health Organisation EURO
Dr Marta Lomazzi, Executive Manager, World Federation of Public Health Associations
Dr Shyam Bishen, Head, Centre for Health and Healthcare and Member of the Executive Committee, World Economic Forum
Dr Karin Tegmark Wisell, Director General, Public Health Agency of Sweden
Antibiotic Stewardship by Anushri Srivastava.pptxAnushriSrivastav
Stewardship is the act of taking good care of something.
Antimicrobial stewardship is a coordinated program that promotes the appropriate use of antimicrobials (including antibiotics), improves patient outcomes, reduces microbial resistance, and decreases the spread of infections caused by multidrug-resistant organisms.
WHO launched the Global Antimicrobial Resistance and Use Surveillance System (GLASS) in 2015 to fill knowledge gaps and inform strategies at all levels.
ACCORDING TO apic.org,
Antimicrobial stewardship is a coordinated program that promotes the appropriate use of antimicrobials (including antibiotics), improves patient outcomes, reduces microbial resistance, and decreases the spread of infections caused by multidrug-resistant organisms.
ACCORDING TO pewtrusts.org,
Antibiotic stewardship refers to efforts in doctors’ offices, hospitals, long term care facilities, and other health care settings to ensure that antibiotics are used only when necessary and appropriate
According to WHO,
Antimicrobial stewardship is a systematic approach to educate and support health care professionals to follow evidence-based guidelines for prescribing and administering antimicrobials
In 1996, John McGowan and Dale Gerding first applied the term antimicrobial stewardship, where they suggested a causal association between antimicrobial agent use and resistance. They also focused on the urgency of large-scale controlled trials of antimicrobial-use regulation employing sophisticated epidemiologic methods, molecular typing, and precise resistance mechanism analysis.
Antimicrobial Stewardship(AMS) refers to the optimal selection, dosing, and duration of antimicrobial treatment resulting in the best clinical outcome with minimal side effects to the patients and minimal impact on subsequent resistance.
According to the 2019 report, in the US, more than 2.8 million antibiotic-resistant infections occur each year, and more than 35000 people die. In addition to this, it also mentioned that 223,900 cases of Clostridoides difficile occurred in 2017, of which 12800 people died. The report did not include viruses or parasites
VISION
Being proactive
Supporting optimal animal and human health
Exploring ways to reduce overall use of antimicrobials
Using the drugs that prevent and treat disease by killing microscopic organisms in a responsible way
GOAL
to prevent the generation and spread of antimicrobial resistance (AMR). Doing so will preserve the effectiveness of these drugs in animals and humans for years to come.
being to preserve human and animal health and the effectiveness of antimicrobial medications.
to implement a multidisciplinary approach in assembling a stewardship team to include an infectious disease physician, a clinical pharmacist with infectious diseases training, infection preventionist, and a close collaboration with the staff in the clinical microbiology laboratory
to prevent antimicrobial overuse, misuse and abuse.
to minimize the developme
Deep Leg Vein Thrombosis (DVT): Meaning, Causes, Symptoms, Treatment, and Mor...The Lifesciences Magazine
Deep Leg Vein Thrombosis occurs when a blood clot forms in one or more of the deep veins in the legs. These clots can impede blood flow, leading to severe complications.
Deep Leg Vein Thrombosis (DVT): Meaning, Causes, Symptoms, Treatment, and Mor...
Pfizer experience
1. PFIZER INC, EXPERIENCE
Strategic and Business Planning
Led process optimization/efficiency and end-to-end redesign initiatives across Clinical Trial Process Excellence to ensure quality is
built-in and enable breakthrough performance - Identified and implemented key measures to establish process controls and asses process
performance. As an example, the Redesign Country and Site Selection Process resulted in an increase of over 200% customer satisfaction
while decreasing cycle time for selection of right site first time.
Developed operational strategies and solutions to harmonize overall business activities for Pfizer Clinical Trial Contracting and
Budgeting. Implemented the Clinical Trial Contracting and Budgeting Business Process management that focuses on customer satisfaction,
agile flow and waste reduction.
Spearheaded the deployment strategy of the Continuous Improvement Program for Business Technology and Finance Business
Operations in the US - Examined strategy results, assessed deployment maturity and readjusted/adapted emerging strategies to instill the
culture of process excellence. As an example: In 2009, Continuous Improvement for Business Technology and Finance Business operation
reached $21 million in hard cost savings (direct cost reduction /cash flow) and $9 million in soft savings (released capacity/cost avoidance).
Created the deployment strategies of the Pfizer Global Travel & Expenses system and processes (Global Concur Expense).
Determined deployment methodology and defined cost-effective, cross-regional and global project teams. Built partnerships with the 4
Pfizer global regions to facilitate GCE implementation planning and create rollout schedule for over 80 markets.
Designed strategies to set up the European Financial Shared Services Contact Center integrating multiple languages for 19 European
Markets.
Cross-Functional Team Leadership & Collaboration
Engaged Functional Lines, Business & Research Units and four (4) Partners around shared objectives for process (re)-design and
execution - worked closely with the Alliance Partners organizations related to process oversight, quality performance review and continuous
process improvement initiatives such as the Redesign of the Clinical Trials Country and Site Selection process impacting an average of 32
global studies per year - average of 10000 recommended Investigator sites with 40% of sites selected.
Acted as Business Process Owner for the Clinical Trial Budgeting and Contracting: Led several teams of colleagues from diverse
organizations such as Study Start Up Units, Business Operations, Clinical and Legal and Alliance Partners to deliver process
improvements and identify oversight for the Clinical Study Agreement process; design a control system including performance
standards and measures; developed SOPs and work instructions to enable robust process compliance
Provided Continuous Improvement and Project Management expertise in support of the Clinical Trial Excellence Program. Led a cross-
functional team of 15 colleagues to recommend solutions for quality-driven clinical trial study level reporting activities through study
closeout.
Led the US Continuous Improvement Program for Business Technology and supported the F&BO deployment strategy resulting in
$10 Million savings in 2009 in the US only – Managed a lean/highly functioning team. Collaborated with F&BO CI leaders to coordinate CI
deployment across Finance and Business Operations.
Managed a cross-functional and global team of 25 colleagues to recommend a new global on-boarding / transfer / off-boarding
process to improve colleagues’ engagement, organizational efficiency, effectiveness and productivity. Reported recommendation to
sponsors (3 ELT members).
Partnered with the Global Continuous Improvement team to deploy best practices and improve deployment efficiency and cost
effectiveness of Continuous Improvement (Blended Training – I-Nexus Deployment – Lean Deployment). Mentored and Coached
Project Leaders to effect changes and deliver project results on time and within budget.
Drove a cross-functional team including Training, Production Support, Technical Support, Accounts Payable and Financial System Support
Departments during the Pfizer Workflow implementation. Proposed and implemented a cost-effective deployment reducing project
cost by 70%.
Change Management and Communication
Created communication campaigns to meet needs of diverse internal and external stakeholder groups and ensure status on major
process performance and remediation/change efforts, such as Global Country and Site Selection Redesign process or Continuous
Improvement Program, were appropriately endorsed
Drove and coordinated the Continuous Improvement training and education process across the US (Sponsor Training - Yellow Belt -
Green Belt). Designed and facilitated business workshops: Voice of Customer Workshops –Kaizen/Impact Events - Developed an
Executive Belt Program and Training for Senior Executive to be effective sponsors and ensure high projects benefits and results.
Led major communication efforts to provide Continuous Improvement visibility at the ELT level (i.e. Global Leaders meeting) and
coordinated Continuous Improvement communication efforts across Business Technology and Finance & Business Operations.
Managed the Global Concur Expense communication and change management initiative to best manage information flow among the
potential 85,000 users, 5 project teams and all stakeholders. Implemented a project communication website providing a central repository
for market implementation information and governance boards materials.
Developed the European Finance Shared Services (EFSS) Application Management communication campaign to best manage
information flow among stakeholders, EFSS, Business IT and in-market customers.